Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPL | P40238 | 5/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25856377 | 0.95 | FFAR4 (0.31) | FFAR4POLBAPEX1HTTTDP1 | |
| SCHEMBL25855037 | 0.94 | FFAR4 (0.30) | FFAR4 | |
| SCHEMBL25856320 | 0.92 | FFAR4 (0.33) | FFAR4 | |
| SCHEMBL25856228 | 0.92 | FFAR4 (0.30) | FFAR4 | |
| SCHEMBL25856324 | 0.91 | NR1H2 (0.30) | — | |
| SCHEMBL25855860 | 0.90 | FFAR4 (0.33) | FFAR4 | |
| SCHEMBL25855605 | 0.90 | MPL (0.32) | MPLFFAR4POLBAPEX1HTT | |
| SCHEMBL25869453 | 0.90 | POLB (0.33) | MPLPOLBAPEX1HTTTDP1 | |
| SCHEMBL25855447 | 0.89 | FFAR4 (0.32) | FFAR4 | |
| SCHEMBL25855999 | 0.89 | NR1H2 (0.33) | POLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023134598-A1 | POLYMERISABLE COMPOUND, COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | 烟台显华科技集团股份有限公司 | 2023-07-20 | — | — | WO | disclosed |
| WO-2023134596-A1 | NEGATIVE DIELECTRIC ANISOTROPIC LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIER, AND LIQUID CRYSTAL DISPLAY COMPONENT | 烟台显华科技集团股份有限公司 | 2023-07-20 | — | — | WO | disclosed |